Upcoming FDA decision · November 23, 2026
LIGAND PHARMACEUTICALS INC PDUFA date: FDA decision expected November 23, 2026
101 days to goLIGAND PHARMACEUTICALS INC (LGNDZ) →
The FDA is expected to decide on LIGAND PHARMACEUTICALS INC from LIGAND PHARMACEUTICALS INC by the PDUFA target action date of November 23, 2026. NDA filing. Extracted from SEC filing: 8-K
A PDUFA date is the FDA's target deadline to complete its review of a drug application — approval, a complete response letter (CRL), or an extension are all possible. What is a PDUFA date? This page is research information, not financial advice.
November 23
Target action date
NDA
Stage
Detected
Date confidence
—
FDA designations